Ankle Exosuit Training in the Clinic to Community Community
1 other identifier
interventional
10
1 country
1
Brief Summary
This study focuses on investigating exosuit technology by evaluating its ability to provide a gait-restorative effect delivered in both clinic and community settings. The exosuit provides dynamic dorsiflexion and plantarflexion assist during walking. We will determine the effect of training parameters of intensity, repetition, and gait quality which are all key parameters associated with experience-dependent neuroplasticity. The other objective is to determine the effect of this intervention on community walking activity, walking speed, walking distance, and locomotor mechanics and energetics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable stroke
Started Jan 2020
Longer than P75 for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 10, 2020
CompletedFirst Submitted
Initial submission to the registry
January 29, 2020
CompletedFirst Posted
Study publicly available on registry
January 31, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedApril 1, 2025
March 1, 2025
6 years
January 29, 2020
March 31, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in 10 Meter Walk Test from baseline gait speed
This test will examine the patient's gait speed. Patients will be directed to walk at their preferred and maximum but safe speed. Patients will be positioned 1 meter before the start line and instructed to walk the entire distance and past the end line approximately 1 meter. The distance before and after the course are meant to minimize the effect of acceleration and deceleration. Time will be recorded using a stopwatch and recorded to the one hundredth of a second (ex: 2.15 sec).
Baseline Day 1-3, Midpoint at week 6, Post-intervention at week 12
Secondary Outcomes (2)
Change in 6 Minute Walk Test in distance from baseline
Baseline Day 1-3, Midpoint at week 6, Post-intervention at week 12
Functional Gait Assessment (FGA)
Baseline Day 1-3, Midpoint at week 6, Post-intervention at week 12
Study Arms (1)
ReWalk Soft Exosuit
EXPERIMENTALDuring this study, we will explore which timing: early timing (10-20%), mid timing (50%) and late timing (90%) may be optimal for an individual and then carry out an 18 session training protocol.
Interventions
Up to 5 bouts of 6 minutes walking on the treadmill with rest breaks allowed between sets
Up to 5 bouts of 6 minutes walking overground with rest breaks allowed between sets
Eligibility Criteria
You may qualify if:
- Age 18 - 80 years old
- Stroke event occurred at least 6 months ago
- Observable gait deficits
- Able to walk without the support of another person for at least 2 minutes (with or without an assistive device or orthotic support)
- Passive ankle dorsiflexion range of motion to neutral with the knee extended (i.e., able to achieve an angle of 90 degrees between the shank and the foot)
- Resting heart rate between 40 - 100 bpm, inclusive
- Resting blood pressure between 90/60 and 170/90 mmHg, inclusive
- Medical clearance by a physician
You may not qualify if:
- Score of \>1 on question 1b and \>0 on question 1c on the NIH Stroke Scale
- Inability to communicate with investigators
- Neglect or hemianopia
- Unexplained dizziness in the last 6 months
- Pressure ulcers or skin wounds located at human-device interface sites
- History of significant Peripheral Artery Disease (PAD)
- Unresolved Deep Vein Thrombosis (DVT)
- Uncontrolled or untreated hypertension
- Significant paretic ankle contractures (plantarflexion \> 5°)
- Psychiatric or cognitive impairments that may interfere with proper operation of the device
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Arun Jayaraman, PT, PhDlead
- U.S. Department of Educationcollaborator
Study Sites (1)
Shirley Ryan AbilityLab
Chicago, Illinois, 60611, United States
Related Publications (1)
Shin SY, Hohl K, Giffhorn M, Awad LN, Walsh CJ, Jayaraman A. Soft robotic exosuit augmented high intensity gait training on stroke survivors: a pilot study. J Neuroeng Rehabil. 2022 Jun 3;19(1):51. doi: 10.1186/s12984-022-01034-2.
PMID: 35655180DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Arun Jayaraman, PT, PhD
Shirley Ryan AbilityLab
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 29, 2020
First Posted
January 31, 2020
Study Start
January 10, 2020
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
April 1, 2025
Record last verified: 2025-03